
|Articles|June 1, 2003
- Volume 0 0
June 2003: Rx Image #1
Advertisement
Pharmacist Marleen Andersen and technician Stefanie Zink of Pamida Pharmacy in Savanna, Ill, were both baffled when trying to decipher this Rx. After several attempts to figure out what medication was being prescribed, they called the physician for help. The physician?s nurse confirmed the Rx and replied, laughing, "You can?t read that?" Can you read this prescription?
Click Here For The Answer ----------->
[
2% Xylocaine gel, 2 week supply, apply to perianal area pm
toggle(getObject('exp1048685570_link'), 'exp1048685570');
Articles in this issue
over 23 years ago
New Strategy Seeks to Improve America's Oral Healthover 23 years ago
Severe Gum Disease May Raise Preeclampsia Riskover 23 years ago
Medication for Menstrual Migrainesover 23 years ago
Healthy Heart Handbook Availableover 23 years ago
BP1 Gene Linked to Breast Cancerover 23 years ago
Prenatal Exposure to Alcoholover 23 years ago
Estrogen Patch Minimizes Cardiovascular Riskover 23 years ago
Diabetes and Gum Diseaseover 23 years ago
Bacteria Cause Fresh Breath?or Halitosisover 23 years ago
Drought in Your Mouth?Advertisement
Related to this article

A current pharmacy resident provides insights on how pharmacy students can manage the transition from student to resident.

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.

Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.

The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Two recent graduates share strategies for standing out in the competitive fellowship application process.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Prescription Volume: Measuring the Pharmacist’s Value
2
Medicare GLP-1 Bridge Runs Outside Part D and Pharmacy Teams Need a Different Workflow
3
FDA Approves Talazoparib With Enzalutamide for HRR-Mutated Metastatic Prostate Cancer
4
GLP-1 RAs, Finerenone, and CKD: Key Data From Kidney Week 2026
5


